KEISHA MACK: Open Payments
NPI 1487964631 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 13 payments from 5 companies in 2025. Trend: 2023 $48 · 2024 $171 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $194 |
| Neurocrine BioSciences, Inc. | 3 | $93 |
| ACADIA Pharmaceuticals Inc | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
Products named: COBENFY, INGREZZA, NUPLAZID, FARXIGA, Ozempic.
Industry payments across NY — which companies pay providers there.
